Search for: "PFIZER V TEVA PHARMACEUTICALS" Results 141 - 160 of 183
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jul 2014, 11:55 am
Teva Pharmaceuticals USA, Inc., 2010 WL 2640170, at *2 (W.D. [read post]
29 Feb 2008, 8:00 am
: (creativecommons.org)Pharma & BiotechPharma & Biotech - GeneralScience Commons news: A commons-sense approach to winning the drug discovery lottery: (creativecommons.org),India: Hindu Business Line reports on why pharma companies are pushing for tax incentives: (Spicy IP), India: J Mitra gets injunction against Span Diagnostics in patent dispute before Delhi High Court over device used in detection of Hep C: (Generic Pharmaceuticals & IP), India: Patent Office… [read post]
18 Feb 2013, 12:46 am by Anubha Sinha
Madhulika reported that the Patent Office revoked Pfizer’s patent on Sunitib- an exorbitantly priced drug. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
14 May 2015, 4:00 am by Paula Bremner
In Apotex v Pfizer Canada, 2014 FCA 250 [celecoxib NOC case], The Court of Appeal was focussed on interpreting the Promise in favour of Pfizer. [read post]
18 Jan 2013, 2:06 pm by Bexis
  The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v… [read post]
1 May 2024, 1:18 pm by Melissa Tremblay
Teva Pharmaceuticals, an AKS-based FCA case involving speaker programs sponsored by drug manufacturers, the U.S. [read post]
2 Jun 2011, 12:46 pm by Bexis
Pfizer, Inc., 153 S.W.3d 758, 761 (Ky. 2004) (dictum also extends rule to medical devices). [read post]
20 Jun 2008, 8:07 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Associated Press – AP files seven DMCA takedowns against Drudge Retort blog over users linking to its stories: (The Trademark Blog), (Techdirt), (Out-Law), (Electronic Frontier Foundation), (IPKat), (The Trademark Blog), ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
5 Apr 2012, 11:54 am by Bexis
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734, at *3 (S.D. [read post]